Close
ACHEMA MIDDLE EAST 2026

Moderna Starts Variant Specific Vaccine Trials After Pfizer

Moderna, the US biotech firm, has announced that it has initiated clinical trials of a booster that is especially designed to fight out the...

Biotech Companies In China Look To Have A Global Footprint

The biotechnology industry in China is coming of age as a major licencing deal has been signed between RemeGen Co Ltd and Seagen Inc,...

Biosimilar Space Disruption Lead By Novartis And Pfizer

As per GlobalData’s Thematic Research ecosystem, pharmaceutical giants Novartis and Pfizer are the best-positioned companies to take advantage of future biosimilars in the pharma...

Moderna To introduce The Fusion Of COVID-19 And Flu Booster

According to Moderna’s CEO, Stephane Bancel, the company is aiming to bring to the market a combination of COVID-19 and influenza booster in the...

Indian Pharmaceutical Industry In 2021 And The Road Ahead

It shouldn’t come as a surprise when we call India a global powerhouse when it comes to generic drugs. The Indian pharmaceutical companies cater...

Abbisko Therapeutics Announces Worldwide Collaboration with Lilly to Discover and Develop Novel Molecules

Abbisko Therapeutics Co., Ltd., a subsidiary of Abbisko Cayman Limited announced that it has entered into a worldwide collaboration and exclusive licensing agreement with...

Moderna to come up with combined Covid and flu booster by 2023

US drugmaker Moderna is working on a combined Covid-19 and flu booster shot, which could be available in some countries by fall 2023 at...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...